The most notable studies in lung cancer at ASCO 2024
The text has been edited for better understanding. Dr. Luis Corrales discusses with Dr. Henry…
0 Comments
New advances in ASCO from Johnson&Johnson for lung cancer
Johnson & Johnson has announced the submission of an application for extension of the marketing…
0 Comments
MEDSIR presents new advances in breast cancer at ASCO for patients with limited therapeutic options
(Information sent by the signatory company) MEDSIR, based in Barcelona and New Jersey, will once…
0 Comments
Astrazeneca presents its advances in lung cancer at ASCO
Astrazeneca advances its ambition to redefine cancer treatment with new data from its industry pipeline…
0 Comments